Hospital services

American Shared Hospital Services Expands Sales Team

Takes on new role as Sales Manager at Healthcare Finance Pro, Tim Keel

SAN FRANCISCO, Calif., May 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the “Company” or “AMS”), a leading provider of turnkey technology solutions for radiosurgery stereotactics and advanced radiation therapy equipment and services, today announced that it has expanded the company’s sales team by hiring Timothy J. Keel as vice president of sales and marketing, responsible for sales and marketing at company-wide, effective May 3, 2022. Ernest R. Bates will become vice president of international sales and marketing.

Timothy J. Keel has over 30 years of experience in the healthcare financing industry. He previously served as Vice President of Sales for Dext Capital, a leading independent healthcare financial firm. Prior to Dext, he held several senior sales positions at BankAmerica, Citibank and Key Bank, focusing on project financing in oncology, day surgery and diagnostic imaging. Mr. Keel holds a Bachelor of Science in Financial Management from California State University of Long Beach.

Ray Stachowiak, Chairman and CEO of AMS, said, “AMS has spent a significant amount of time building its financial resources and foundation to position the company for its next phase of growth. An important part of this plan was to add new direction to our company’s sales and marketing efforts, and we are delighted to have hired Tim Keel for this role. Craig Tagawa, President, COO and CFO of AMS, and I have known Tim for 25 years, and his extensive healthcare sales experience, as well as his knowledge of project finance and his relationships with hospitals, medical development contractors, and medical equipment suppliers, make him an excellent candidate to join American Shared Hospital Services at this time. With the pandemic waning, the US healthcare market is ripe for the placement of additional advanced radiation therapy equipment, and with our expanded product portfolio, now was the time to redouble our efforts in all markets. We welcome Tim to AMS and look forward to his contributions. »

“AMS’s growth will also benefit from the joint venture we recently announced to install a state-of-the-art linear accelerator for a radiation therapy center in Puebla, Mexico. This agreement was conceived and negotiated during the COVID-19 pandemic and its realization is due to the tenacity of Ernie Bates. This is our third project outside of the United States and Ernie’s knowledge and experience of international markets has been instrumental in this growth,” concluded Stachowiak.

About American Hospital Shared Services (NYSE American: AMS)

American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. AMS is a leading supplier of Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The company also offers proton therapy and the latest IGRT, IMRT and MR/LINAC systems. For more information, visit:

Safe Harbor Statement

This press release may be deemed to contain certain forward-looking statements regarding the financial condition, results of operations and future plans of American Shared Hospital Services (including statements regarding the company’s expected continued growth and the expansion of Gamma Company’s Knife, proton therapy and MR/LINAC businesses, which involve risks and uncertainties, including but not limited to risks relating to economic and market conditions, risks of variability in financial results between the quarters, the risks of the Gamma Knife and proton therapy activities, the risks related to the development of The Operating Room for the 21st Century program, the risks of changes in the reimbursement rates or the CMS reimbursement methodology, the risks related to the schedule, the financing and operations of the Company’s Gamma Knife, proton therapy and MR/LINAC activities, the risks of the pandemic ie of COVID-19 and its effect on the Company’s business activities and financial condition, the risk of expansion within or into new markets, the risk that the integration or continuation of operations of acquired businesses may adversely affect financial results and the risk that current and future acquisitions may adversely affect the Company’s financial condition. Additional information about potential factors that could affect American Shared Hospital Services’ financial condition, results of operations and future plans is included in the company’s filings with the Securities and Exchange Commission, including the company’s annual report on Form 10-K for the fiscal year ended December 31, 2021, and the definitive proxy statement for the annual meeting of shareholders to be held on June 21, 2022.

American Shared Hospital Services
Ray Stachowiak
Chief executive officer
Investor Relations
PCG Notice
Stephanie Prince
T.: (646) 863-6341